Logo

PrecisionMed and Phenomenome Discoveries to Co-Develop Metabolite-Based Diagnostics for Alzheimer s, Bipolar Disorder

Feb 04, 2005

NEW YORK, Feb. 4 (GenomeWeb News) - PrecisionMed and Phenomenome Discoveries will collaborate to develop diagnostics for Alzheimer's disease and bipolar disorder, the companies said today.

 

Phenomenome, based in Saskatoon, Canada, will contribute its metabolomics technology to find metabolites that differ between patients and controls.

 

PrecisionMed, a human biobank located in San Diego, will provide clinical samples and information.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.